A detailed history of Amalgamated Bank transactions in Kempharm, Inc stock. As of the latest transaction made, Amalgamated Bank holds 1,825 shares of KMPH stock, worth $9,015. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,825
Previous 1,170 55.98%
Holding current value
$9,015
Previous $10,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025

BUY
N/A
655 Added 55.98%
1,825 $14,000
Q1 2024

Apr 23, 2024

SELL
N/A
-1,856 Reduced 61.34%
1,170 $7,000
Q4 2023

Feb 06, 2024

SELL
N/A
-348 Reduced 10.31%
3,026 $20,000
Q2 2023

Aug 11, 2023

BUY
$4.94 - $6.29 $16,667 - $21,222
3,374 New
3,374 $16,000
Q2 2022

Aug 15, 2022

SELL
$4.02 - $5.21 $16,807 - $21,783
-4,181 Closed
0 $0
Q1 2022

Jun 30, 2022

BUY
$5.0 - $9.26 $20,905 - $38,716
4,181 New
4,181 $21,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.